Q QUEST DIAGNOSTICS INC
| Market Cap | $22.03B |
| P/E Ratio | 22.63 |
| Forward P/E | 17.25 |
| Dividend Yield | 1.74% |
| Beta | 0.65 |
| 52W Range | $157.65 - $211.91 |
| # Hedge Funds | 4 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Hedge Fund Ownership
| Investor 4 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Robert Olstein Olstein Capital Management | 1.38% | $6.00K | 40,000 | — |
| Christopher Davis Davis Selected Advisers | 1.24% | $275.89M | 1,589,883 | Add 16.76% |
| Lee Ainslie Maverick Capital | 0.04% | $4.15M | 23,895 | Add 31.45% |
| First Eagle Investment Management First Eagle Investment Management | 0.00% | $682.00K | 3,935 | Add 2.61% |
Insider Trading
| Insider Name of the company insider who made the trade 33 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | 3,878 | $206.21 | $799.68K | 05 Mar 2026 | 06 Mar 2026 |
| Doherty Catherine T.EVP, Regional Businesses | Sale | 5,558 | $206.21 | $1.15M | 05 Mar 2026 | 06 Mar 2026 |
| Plewman PatrickSVP for Diagnostic Services | Sale | 2,855 | $206.21 | $588.73K | 05 Mar 2026 | 06 Mar 2026 |
| Catherine T. DohertyEVP, Regional Businesses | Sale | 5,558 | $206.21 | $1.15M | 05 Mar 2026 | 06 Mar 2026 |
| Michael E PrevoznikSVP & General Counsel | Sale | 3,878 | $206.21 | $799.68K | 05 Mar 2026 | 06 Mar 2026 |
| Patrick PlewmanSVP for Diagnostic Services | Sale | 2,855 | $206.21 | $588.73K | 05 Mar 2026 | 06 Mar 2026 |
| KUPPUSAMY KARTHIKSVP, Clinical Solutions | Sale | 2,628 | $204.86 | $538.37K | 04 Mar 2026 | 06 Mar 2026 |
| Karthik KuppusamySVP, Clinical Solutions | Sale | 2,628 | $204.86 | $538.37K | 04 Mar 2026 | 06 Mar 2026 |
| Plewman PatrickSVP for Diagnostic Services | Sale | 410 | $207.73 | $85.17K | 03 Mar 2026 | 04 Mar 2026 |
| Doherty Catherine T.EVP, Regional Businesses | Sale | 632 | $207.73 | $131.29K | 03 Mar 2026 | 04 Mar 2026 |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | 526 | $207.73 | $109.27K | 03 Mar 2026 | 04 Mar 2026 |
| Davis J. E.CEO and President | Sale | 10,000 | $212.52 | $2.13M | 02 Mar 2026 | 04 Mar 2026 |
| Plewman PatrickSVP for Diagnostic Services | Sale | 958 | $204.83 | $196.23K | 19 Feb 2026 | 20 Feb 2026 |
| PREVOZNIK MICHAEL ESVP & General Counsel | Sale | 1,111 | $204.83 | $227.57K | 19 Feb 2026 | 20 Feb 2026 |
| Doherty Catherine T.EVP, Regional Businesses | Sale | 1,433 | $204.83 | $293.52K | 19 Feb 2026 | 20 Feb 2026 |
| Doherty Catherine T.EVP, Regional Businesses | Sale | 1,619 | $208.21 | $337.09K | 13 Feb 2026 | 17 Feb 2026 |
| Doherty Catherine T.EVP, Regional Businesses | Sale | 10,573 | $205.21 | $2.17M | 13 Feb 2026 | 17 Feb 2026 |
| Doherty Catherine T.EVP, Regional Businesses | Sale | 351 | $209.10 | $73.39K | 13 Feb 2026 | 17 Feb 2026 |
| Doherty Catherine T.EVP, Regional Businesses | Sale | 3,500 | $207.08 | $724.79K | 13 Feb 2026 | 17 Feb 2026 |
| Doherty Catherine T.EVP, Regional Businesses | Sale | 10,122 | $206.37 | $2.09M | 13 Feb 2026 | 17 Feb 2026 |
| Plewman PatrickSVP for Diagnostic Services | Sale | 5,662 | $204.00 | $1.16M | 10 Feb 2026 | 12 Feb 2026 |
| Davis J. E.CEO and President | Sale | 4,747 | $192.97 | $916.04K | 25 Nov 2025 | 28 Nov 2025 |
| Davis J. E.CEO and President | Sale | 9,342 | $191.59 | $1.79M | 25 Nov 2025 | 28 Nov 2025 |
| Davis J. E.CEO and President | Sale | 41,004 | $192.27 | $7.88M | 25 Nov 2025 | 28 Nov 2025 |
| Gregg Vicky B | Sale | 1,250 | $191.76 | $239.70K | 25 Nov 2025 | 28 Nov 2025 |
| E. J. DavisCEO and President | Sale | 41,004 | $192.27 | $7.88M | 25 Nov 2025 | 28 Nov 2025 |
| Vicky B GreggDirector | Sale | 1,250 | $191.76 | $239.70K | 25 Nov 2025 | 28 Nov 2025 |
| E. J. DavisCEO and President | Sale | 4,747 | $192.97 | $916.04K | 25 Nov 2025 | 28 Nov 2025 |
| E. J. DavisCEO and President | Sale | 9,342 | $191.59 | $1.79M | 25 Nov 2025 | 28 Nov 2025 |
| DELANEY MARK ESVP & Chief Commercial Officer | Sale | 7,946 | $187.35 | $1.49M | 18 Nov 2025 | 20 Nov 2025 |
| Mark E DelaneySVP & Chief Commercial Officer | Sale | 7,946 | $187.35 | $1.49M | 18 Nov 2025 | 20 Nov 2025 |
| PFEIFFER GARY M | Sale | 1,482 | $182.40 | $270.32K | 22 Oct 2025 | 24 Oct 2025 |
| Gary M PfeifferDirector | Sale | 1,482 | $182.40 | $270.32K | 22 Oct 2025 | 24 Oct 2025 |
Frequently Asked Questions
What is DGX stock price today?
QUEST DIAGNOSTICS INC (DGX) is currently trading at $198.02. The stock has a 52-week range of $157.65 to $211.91 and a market capitalization of $22.03B.
Is DGX a good stock to buy in 2026?
QUEST DIAGNOSTICS INC has a P/E ratio of 22.6 (forward P/E: 17.2), a dividend yield of 1.74%, and 1-year performance of +18.2%. 4 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling DGX stock?
There have been 33 insider transactions for DGX in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has DGX stock performed over the past year?
QUEST DIAGNOSTICS INC (DGX) has returned +18.2% over the past 12 months. The stock traded between $157.65 and $211.91 during this period, and is currently at $198.02.
Which hedge funds own DGX (QUEST DIAGNOSTICS INC)?
4 tracked hedge funds currently hold DGX in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is DGX's market cap and valuation?
QUEST DIAGNOSTICS INC (DGX) has a market capitalization of $22.03B. The trailing P/E ratio is 22.6 and forward P/E is 17.2. The stock is classified in the Healthcare sector.
What is DGX's revenue and profitability?
QUEST DIAGNOSTICS INC reported revenue of $11.03B with net income of $988.00M and a profit margin of 0.09%. The stock has a beta of 0.65.
What sector is DGX in and who are its biggest institutional holders?
QUEST DIAGNOSTICS INC (DGX) operates in the Healthcare sector. It is held by 4 tracked hedge funds. See the ownership table above for the complete list.